TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/13/23 18:56 | 10/13/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lis William | CA | D | S | -7 | 0.8508 | 0 | -8 | -13 | 54 | D | |||||||||||||||
4/14/23 16:14 | 4/13/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lis William | CA | D | S | -12 | 1.44 | 0 | -9 | -12 | 61 | D | |||||||||||||||
3/7/23 16:05 | 3/3/23 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Lis William | MA | D | S | -208 | 38.31 | 0 | -5 | -19 | 23 | D | |||||||||||||||
6/28/22 16:01 | 6/24/22 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lis William | CA | D | S.m | -101 | 2.05 | 0 | -49 | -55 | 40 | D | |||||||||||||||
1/21/22 17:10 | 1/20/22 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Lis William | F4 | D | S | -103 | 53.40 | 0 | -2 | -5 | 34 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |